tiprankstipranks
Everest Medicines Ltd. (HK:1952)
:1952
Hong Kong Market

Everest Medicines Ltd. (1952) Income Statement

Compare
2 Followers

Everest Medicines Ltd. Income Statement

Last quarter (Q1 2024), Everest Medicines Ltd.'s total revenue was ¥150.76M, an increase of 3289.74% from the same quarter last year. In Q1, Everest Medicines Ltd.'s net income was ¥-316.21M. See Everest Medicines Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
¥ 125.93M¥ 12.79M¥ 54.00K¥ 0.00¥ 0.00
Gross Profit
¥ 91.52M¥ 8.15M¥ 31.00K¥ 0.00¥ 0.00
Operating Expenses
¥ 1.02B¥ 1.41B¥ 1.05B¥ 687.41M¥ 198.53M
Depreciation and Amortization
¥ 76.78M¥ 42.77M¥ 31.12M¥ 4.48M¥ 2.80M
EBITDA
¥ -744.63M¥ -198.91M¥ -972.78M¥ -683.03M¥ -195.72M
Operating Income
¥ -932.74M¥ -1.40B¥ -1.05B¥ -688.46M¥ -176.11M
Other Income/Expenses
¥ 88.28M¥ 9.53M¥ 17.61M¥ -4.97B¥ -38.40M
Pretax Income
¥ -844.46M¥ -247.28M¥ -1.01B¥ -5.66B¥ -214.51M
Net Income
¥ -844.46M¥ -247.28M¥ -1.01B¥ -5.68B¥ -193.47M
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ -2.70¥ -0.83¥ -3.46¥ -26.46¥ -0.68
Diluted EPS
¥ -2.70¥ -0.83¥ -3.46¥ -26.46¥ -0.68
Weighted Average Shares Outstanding
313.06M 297.63M 293.23M 214.75M 283.69M
Weighted Average Shares Outstanding (Diluted)
313.06M 297.63M 293.27M 214.75M 283.69M
Currency in CNY

Everest Medicines Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis